Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556878 · ClinicalTrials.gov registry record · NA
Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment
A NA study of Sleep Disorder and Implementation Research, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03556878: Completed NA study of Sleep Disorder and Implementation Research, sponsored by University of California, Berkeley.
NCT03556878 is a NA study of Sleep Disorder and Implementation Research that has completed, run by University of California, Berkeley. The registered enrollment target is 21 participants, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556878, a NA study of Sleep Disorder and Implementation Research, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C), referred to as 'Fitted TranS-C'.
Primary Outcome
The AIM is a measure of the extent to which the intervention is acceptable to providers. The AIM is comprised of 4 questions rated on a 1 'completely disagree' to 5 'completely agree' scale. The responses to all four qus will be reported along with the summed total score.
Conditions Studied
Interventions
- BEHAVIORAL Fitted Transdiagnostic Sleep and Circadian intervention
Study Locations (1)
California
- UC Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2018-12-01 |
| Phase | NA |
What the finished NCT03556878 record still lists
NCT03556878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (87% lower).
The record links to 6 conditions, with Sleep Disorder appearing as the primary indexed condition, and to 1 intervention - of which Fitted Transdiagnostic Sleep and Circadian intervention is the first listed.
NCT03556878 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03556878 about?
NCT03556878 is a clinical study titled "Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment". The goal is to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C), referred to as 'Fitted TranS-C'.
What is the current status of trial NCT03556878?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-07-20. Estimated completion is 2018-12-01.
What conditions does trial NCT03556878 study?
This clinical trial studies the following conditions: Sleep Disorder, Implementation Research, Acceptability, Sleep Disorders, Circadian Rhythm, Feasibility.
What interventions are being tested in trial NCT03556878?
The interventions under investigation include: Fitted Transdiagnostic Sleep and Circadian intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03556878?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03556878 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03556878's enrollment target sits among peer trials
21 22nd of 22 higher than 1 of 22 other Sleep Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
RECRUITING · NA
-
Pilot Study of BCAA on Sleep
RECRUITING · NA
-
Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
COMPLETED · NA
-
The Yoga and Insomnia Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI